Related Experiment Videos
[A rare complication of cisplatin: Lhermitte's sign]
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.
ESMO gastrointestinal oncology·2026
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer.
Molecular oncology·2026
p16 Overexpression and Human Papillomavirus Positivity in More Than 1000 Penile Cancers.
International journal of cancer·2026
Effect of Functional Groups Introduced into Radioiodinated Asymmetric Cyanine Dyes on Their In Vivo Behavior.
Molecular pharmaceutics·2026